Concepedia

Joanna Opalińska

JO

Statistics

Publications

14

Citations

809

H-Index

12

Active since

1997

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Providence College

National and Kapodistrian University of Athens

University Medical Center Hamburg-Eppendorf

Joanna Opalińska is an author at GlaxoSmithKline (United States) specializing in medicine, multiple myeloma, and multiple myeloma treatment.

Publications per year

1997–2025

14

Publications

14

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Vânia Hungria, Paweł Robak, Marek Hus et al. · New England Journal of Medicine · 2024 · 166 citations

, , +13

Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma

Meletios Α. Dimopoulos, Meral Beksac, Luděk Pour et al. · New England Journal of Medicine · 2024 · 151 citations

, , +15

Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · Cancer · 2021 · 143 citations · Full text

, , +13

Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study

Meletios Α. Dimopoulos, Vânia Hungria, Atanas Radinoff et al. · The Lancet Haematology · 2023 · 124 citations

, , +13

Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma

Amanda Bruno, Jenny Willson, Joanna Opalińska et al. · Expert Review of Hematology · 2020 · 46 citations · Full text

, , +14

1–5 of 14